Follow
Mingyue Zheng
Mingyue Zheng
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Verified email at simm.ac.cn - Homepage
Title
Cited by
Cited by
Year
Pushing the boundaries of molecular representation for drug discovery with the graph attention mechanism
Z Xiong, D Wang, X Liu, F Zhong, X Wan, X Li, Z Li, X Luo, K Chen, ...
Journal of medicinal chemistry 63 (16), 8749-8760, 2019
7562019
In silico ADME/T modelling for rational drug design
Y Wang, J Xing, Y Xu, N Zhou, J Peng, Z Xiong, X Liu, X Luo, C Luo, ...
Quarterly reviews of biophysics 48 (4), 488-515, 2015
3602015
TransformerCPI: improving compound–protein interaction prediction by sequence-based deep learning with self-attention mechanism and label reversal experiments
L Chen, X Tan, D Wang, F Zhong, X Liu, T Yang, X Luo, K Chen, H Jiang, ...
Bioinformatics 36 (16), 4406-4414, 2020
3292020
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor
C Xie, X Wan, H Quan, M Zheng, L Fu, Y Li, L Lou
Cancer science 109 (4), 1207-1219, 2018
3112018
Artificial intelligence in drug design
F Zhong, J Xing, X Li, X Liu, Z Fu, Z Xiong, D Lu, X Wu, J Zhao, X Tan, F Li, ...
Science China Life Sciences 61, 1191-1204, 2018
2152018
Graph neural networks for automated de novo drug design
J Xiong, Z Xiong, K Chen, H Jiang, M Zheng
Drug discovery today 26 (6), 1382-1393, 2021
1782021
Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities
J Li, M Zheng, W Tang, PL He, W Zhu, T Li, JP Zuo, H Liu, H Jiang
Bioorganic & medicinal chemistry letters 16 (19), 5009-5013, 2006
1582006
Optimization of metabolomic data processing using NOREVA
J Fu, Y Zhang, Y Wang, H Zhang, J Liu, J Tang, Q Yang, H Sun, W Qiu, ...
Nature protocols 17 (1), 129-151, 2022
1522022
Regulating glucose metabolism with prodrug nanoparticles for promoting photoimmunotherapy of pancreatic cancer
F Sun, Q Zhu, T Li, M Saeed, Z Xu, F Zhong, R Song, M Huai, M Zheng, ...
Advanced Science 8 (4), 2002746, 2021
1442021
Generative models for de novo drug design
X Tong, X Liu, X Tan, X Li, J Jiang, Z Xiong, T Xu, H Jiang, N Qiao, ...
Journal of Medicinal Chemistry 64 (19), 14011-14027, 2021
1412021
Identifying Novel Selective Non-Nucleoside DNA Methyltransferase 1 Inhibitors through Docking-Based Virtual Screening
S Chen, Y Wang, W Zhou, S Li, J Peng, Z Shi, J Hu, YC Liu, H Ding, Y Lin, ...
Journal of Medicnal Chemistry 57 (21), 9028–9041, 2014
1242014
Astemizole arrests the proliferation of cancer cells by disrupting the EZH2-EED interaction of polycomb repressive complex 2
X Kong, L Chen, L Jiao, X Jiang, F Lian, J Lu, K Zhu, D Du, J Liu, H Ding, ...
Journal of medicinal chemistry 57 (22), 9512-9521, 2014
1172014
Graph neural network approaches for drug-target interactions
Z Zhang, L Chen, F Zhong, D Wang, J Jiang, S Zhang, H Jiang, M Zheng, ...
Current Opinion in Structural Biology 73, 102327, 2022
1122022
Discovery of highly potent, selective, and orally efficacious p300/CBP histone acetyltransferases inhibitors
Y Yang, R Zhang, Z Li, L Mei, S Wan, H Ding, Z Chen, J Xing, H Feng, ...
Journal of medicinal chemistry 63 (3), 1337-1360, 2020
1122020
Aspirin inhibits cancer metastasis and angiogenesis via targeting heparanase
X Dai, J Yan, X Fu, Q Pan, D Sun, Y Xu, J Wang, L Nie, L Tong, A Shen, ...
Clinical Cancer Research 23 (20), 6267-6278, 2017
1102017
Computational methods for drug design and discovery: focus on China
M Zheng, X Liu, Y Xu, H Li, C Luo, H Jiang
Trends in pharmacological sciences 34 (10), 549-559, 2013
1052013
Site of metabolism prediction for six biotransformations mediated by cytochromes P450
M Zheng, X Luo, Q Shen, Y Wang, Y Du, W Zhu, H Jiang
Bioinformatics 25 (10), 1251-1258, 2009
1002009
Computational screening for active compounds targeting protein sequences: methodology and experimental validation
F Wang, D Liu, H Wang, C Luo, M Zheng, H Liu, W Zhu, X Luo, J Zhang, ...
Journal of chemical information and modeling 51 (11), 2821-2828, 2011
932011
Focused combinatorial library design based on structural diversity, druglikeness and binding affinity score
G Chen, S Zheng, X Luo, J Shen, W Zhu, H Liu, C Gui, J Zhang, M Zheng, ...
Journal of combinatorial chemistry 7 (3), 398-406, 2005
922005
Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
J Gao, B Hou, Q Zhu, L Yang, X Jiang, Z Zou, X Li, T Xu, M Zheng, ...
Nature Communications 13 (1), 4318, 2022
902022
The system can't perform the operation now. Try again later.
Articles 1–20